<?xml version="1.0" encoding="UTF-8"?>
<p id="Par50">In this article, we will briefly describe the most promising and cost/accessible drugs. The widespread use of several new antiviral drugs, as well as already marked monoclonal antibodies, becomes difficult due to their high cost and lack of availability. Precision medicine has to take into in account these issues.</p>
